These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7769318)

  • 1. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
    Baird JK; Basri H; Subianto B; Fryauff DJ; McElroy PD; Leksana B; Richie TL; Masbar S; Wignall FS; Hoffman SL
    J Infect Dis; 1995 Jun; 171(6):1678-82. PubMed ID: 7769318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
    Fryauff DJ; Baird JK; Basri H; Wiady I; Purnomo ; Bangs MJ; Subianto B; Harjosuwarno S; Tjitra E; Richie TL; Hoffman SL
    Ann Trop Med Parasitol; 1997 Jan; 91(1):7-16. PubMed ID: 9093424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of chloroquine plus primaquine for the treatment of Plasmodium vivax malaria in Hamusit site, Northwestern Ethiopia.
    Gebrie H; Yimer M; Ayehu A; Mohammed H; Hailgiorgis H; Wuletaw Y; Hailu M; Tolera G; Tasew G; Kassa M; Gidey B
    Malar J; 2024 Jul; 23(1):202. PubMed ID: 38971786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America.
    Phillips EJ; Keystone JS; Kain KC
    Clin Infect Dis; 1996 Nov; 23(5):1171-3. PubMed ID: 8922821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan.
    Valibayov A; Abdullayev F; Mammadov S; Gasimov E; Sabatinelli G; Kondrachine AV; Ringwald P
    Acta Trop; 2003 Sep; 88(1):99-102. PubMed ID: 12943984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping.
    Taylor WR; Doan HN; Nguyen DT; Tran TU; Fryauff DJ; Gómez-Saladín E; Kain KC; Le DC; Baird JK
    Am J Trop Med Hyg; 2000 Jun; 62(6):693-7. PubMed ID: 11304056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
    Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
    Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of resistance to chloroquine by Plasmodium vivax in Myanmar.
    Marlar-Than ; Myat-Phone-Kyaw ; Aye-Yu-Soe ; Khaing-Khaing-Gyi ; Ma-Sabai ; Myint-Oo
    Trans R Soc Trop Med Hyg; 1995; 89(3):307-8. PubMed ID: 7660445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of Anopheles darlingi fed on patients infected with Plasmodium vivax before and during treatment with chloroquine plus primaquine in Costa Marques, Rondönia, Brazil.
    Klein TA; Tada MS; Lima JB; Tang AT
    Mem Inst Oswaldo Cruz; 1992; 87(2):191-5. PubMed ID: 1308564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
    Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
    Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stage of Plasmodium vivax in central China is still susceptible to chloroquine plus primaquine combination therapy.
    Zhu G; Lu F; Cao J; Zhou H; Liu Y; Han ET; Gao Q
    Am J Trop Med Hyg; 2013 Jul; 89(1):184-7. PubMed ID: 23669232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short course schemes for vivax malaria treatment].
    da Silva Rdo S; Pinto AY; Calvosa VS; de Souza JM
    Rev Soc Bras Med Trop; 2003; 36(2):235-9. PubMed ID: 12806460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
    PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.